<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02128555</url>
  </required_header>
  <id_info>
    <org_study_id>12/0518</org_study_id>
    <secondary_id>12/35/27</secondary_id>
    <secondary_id>ISRCTN60672307</secondary_id>
    <secondary_id>U1111-1157-4155</secondary_id>
    <nct_id>NCT02128555</nct_id>
    <nct_alias>NCT01518361</nct_alias>
  </id_info>
  <brief_title>Total Ankle Replacement Versus Arthrodesis Trial</brief_title>
  <acronym>TARVA</acronym>
  <official_title>A Randomised, Multi-centre, Non-blinded, Prospective, Parallel Group Trial of Total Ankle Replacement (TAR) Versus Ankle Arthrodesis in Patients With End Stage Ankle Osteoarthritis, Comparing Clinical Outcomes and Cost-effectiveness.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University College, London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute for Health Research, United Kingdom</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University College, London</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of TARVA is to determine whether Total Ankle Replacement (TAR) provides better
      clinical outcomes than ankle arthrodesis in patients aged 50-85 years with end-stage ankle
      osteoarthritis, and compare cost-effectiveness of the two treatments
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomised, multi-centre, non-blinded, prospective, parallel-group trial of TAR
      versus ankle arthrodesis in patients with end-stage ankle osteoarthritis (OA) aged between 50
      and 85 years, comparing clinical outcomes (pain-free function, quality of life (QoL), range
      of motion (ROM), and rate of post-procedural complications) and cost-effectiveness. TARVA is
      a clinician-led, pragmatic, superiority trial designed to compare the improvement in
      pain-free function, as assessed by the Manchester-Oxford Foot Questionnaire (MOXFQ)
      walking/standing domain score from pre-op to 52 weeks post-op for each surgical treatment
      group. A total of 328 patients will be randomly allocated on an equal basis to one of two
      surgical treatments: i) Total Ankle Replacement; and ii) Ankle Arthrodesis. Randomisation
      will be stratified by surgeon and presence of OA in two adjacent joints as determined by a
      pre-operative MRI scan.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2015</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Self-reported pain-free function domain score</measure>
    <time_frame>Pre-operation (baseline) to 52 weeks</time_frame>
    <description>To compare the improvement in self-reported pain-free function domain score from pre-op to 52 weeks post-op for TAR versus arthrodesis, assessed by MOXFQ walking/standing domain scores.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Self-reported pain-free function domain score</measure>
    <time_frame>Pre-operation (baseline) to 26 weeks</time_frame>
    <description>To compare the improvement in self-reported pain-free function domain score from pre-op to 26 weeks post-op for TAR versus arthrodesis, assessed by MOXFQ walking/standing domain scores.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported pain and social interaction domain score</measure>
    <time_frame>Pre-operation (baseline) to 26 and 52 weeks</time_frame>
    <description>To compare the improvement in self-reported pain and social interaction domain scores from pre-op to 26 and 52 weeks post-op for TAR versus arthrodesis, assessed by MOXFQ.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported physical function</measure>
    <time_frame>Pre-operation (baseline) to 26 and 52 weeks</time_frame>
    <description>To compare the improvement in self-reported physical function from pre-op to 26 and 52 weeks post-op of TAR versus arthrodesis, assessed by the Foot and Ankle Ability Measure (FAAM) questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported quality of life</measure>
    <time_frame>Pre-operation (baseline) to 26 and 52 weeks</time_frame>
    <description>To compare the improvement in QoL from pre-op to 26 and 52 weeks post-op of TAR versus arthrodesis, assessed by EQ-5D.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of Motion</measure>
    <time_frame>Pre-operation (baseline) to 52 weeks</time_frame>
    <description>To compare the change in total ROM (plantarflexion and dorsiflexion) from pre-op to 52 weeks post-op of TAR versus arthrodesis, assessed by goniometer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>52 weeks</time_frame>
    <description>To compare the safety of TAR versus arthrodesis in terms of complications and adverse events.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental cost and cost-effectiveness</measure>
    <time_frame>52 weeks</time_frame>
    <description>To compare the incremental cost and cost-effectiveness of TAR versus arthrodesis by recording cost of all components and procedure-related costs for each surgical treatment, and using self-reported data from the Health and Social Care Services Use questionnaire.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">328</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Arthrodesis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ankle arthrodesis (fusion)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Total Ankle Replacement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Total Ankle Replacement</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Total Ankle Replacement</intervention_name>
    <description>The joints are resurfaced with metal implants and a mobile plastic liner is placed between them as the gliding surface.</description>
    <arm_group_label>Total Ankle Replacement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Arthrodesis</intervention_name>
    <description>The remaining damaged cartilage is removed from the ends of the bone and the two bones are then held together in compression using screws, or plates until they join to become one (bone fusion), so that there is no longer any movement at that joint.</description>
    <arm_group_label>Arthrodesis</arm_group_label>
    <other_name>Fusion</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of end-stage ankle osteoarthritis

          -  Aged 50-85 years inclusive

          -  The surgeon believes the patient is suitable for both TAR and arthrodesis (having
             considered deformity, stability, bone quality, soft tissue envelope, and neurovascular
             status)

          -  The patient is able to read and understand the Patient Information Sheet (PIS) and
             trial procedures

          -  The patient is willing and able to provide written informed consent

        Exclusion Criteria:

          -  Previous ipsilateral talonavicular, subtalar or calcaneocuboid fusion or surgery
             planned within 1 year of index procedure

          -  More than 4 lower limb joints fused (including contralateral limb, but excluding
             proximal interphalangeal joint fusions)

          -  â€¢ Unable to have MRI/CT scan (e.g. severe claustrophobia or contraindication for
             either scan)

          -  History of local bone or joint infection

          -  Any co-morbidity, which, in the opinion of the investigator, is severe enough to;
             interfere with the patient's ability to complete the study assessments or; presents an
             unacceptable risk to the patient's safety

          -  Participant in another clinical trial that would materially impact on their
             participation in this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew Goldberg</last_name>
    <role>Principal Investigator</role>
    <affiliation>Royal National Orthopaedic Hospital NHS Trust</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Deirdre Brooking</last_name>
    <phone>020 8385 3402</phone>
    <email>deirdre.brooking@rnoh.nhs.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Royal Cornwall Hospitals NHS Trust</name>
      <address>
        <city>Truro</city>
        <state>Cornwall</state>
        <zip>TR1 3LQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabbie Young</last_name>
      <phone>01872 255172</phone>
      <email>Gabbie.young1@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Mike Butler</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brighton &amp; Sussex University Hospitals NHS Trust</name>
      <address>
        <city>Brighton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Newman</last_name>
      <email>julie.newman@bsuh.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Stephen Bendall</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>North Bristol NHS Trust</name>
      <address>
        <city>Bristol</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liz Barnett</last_name>
      <phone>0117 4148120</phone>
      <email>Elizabeth.Barnett@nbt.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Stephen Hepple</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>William Harries</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ian Winson</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiff and Vale Orthopaedic Centre</name>
      <address>
        <city>Cardiff</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cheryl Cleary</last_name>
      <phone>02920 716689</phone>
      <email>cheryl.cleary@wales.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Rhys Thomas</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Derby Hospital</name>
      <address>
        <city>Derby</city>
        <zip>DE22 3NE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charlene Otieno</last_name>
      <phone>01332 786005</phone>
      <email>tracy.brear@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Steve Milner</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Surrey County Hospital</name>
      <address>
        <city>Guildford</city>
        <zip>GU2 7XX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kate Jardine</last_name>
      <email>kate.jardine@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Paul Halliwell</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hull and East Yorkshire Hospitals NHS Trust</name>
      <address>
        <city>Hull</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emma Clarkson</last_name>
      <phone>01482 675630</phone>
      <email>EmmaP.Clarkson@hey.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Viren Mishra</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aintree University Hospital</name>
      <address>
        <city>Liverpool</city>
        <zip>L9 7AL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sharon Griffiths</last_name>
      <phone>0151 529 2542</phone>
      <email>sharon.griffiths@aintree.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Pearly George</last_name>
      <email>pearly.george@aintree.nhs.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Andy Molloy</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Clifford Butcher</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Freeman Hospital</name>
      <address>
        <city>Newcastle</city>
        <zip>NE7 7DN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katie Merrie</last_name>
      <phone>0191 223 1514</phone>
      <email>Katie.Merrie@nuth.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Malik Siddique</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paulo Torres</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northumbria Healthcare NHS Foundation Trust</name>
      <address>
        <city>Newcastle</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah Bunn</last_name>
      <email>deborah.bunn@northumbria-healthcare.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>David Townshend</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rajesh Kakwani</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>An Murty</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Norfolk and Norwich University Hospitals NHS Foundation Trust</name>
      <address>
        <city>Norwich</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tracey Potter</last_name>
      <email>tracey.potter@nnuh.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Elizabeth Saunders</last_name>
      <email>elizabeth.saunders@nnuh.nhs.uk</email>
    </contact_backup>
    <investigator>
      <last_name>David Loveday</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>George Smith</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nottingham University Hospitals NHS Trust</name>
      <address>
        <city>Nottingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katie Lee</last_name>
      <email>katie.lee2@nuh.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Sunil Dhar</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Martin Raglan</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Robert Jones &amp; Agnes Hunt Orthopaedic Hospital</name>
      <address>
        <city>Oswestry</city>
        <zip>SY10 7AG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Turner</last_name>
      <phone>01691 404418</phone>
      <email>Sarah.turner2@rjah.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Andrew Bing</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oxford University Hospitals NHS Foundation Trust</name>
      <address>
        <city>Oxford</city>
        <zip>OX3 7LD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Doig</last_name>
      <phone>01865 737417</phone>
      <email>karen.doig@ndorms.ox.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Paul Cooke</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bob Sharp</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mark Rogers</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northern General Hospital</name>
      <address>
        <city>Sheffield</city>
        <zip>S5 7AU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angela Green</last_name>
      <phone>0114 271 5779</phone>
      <email>angela.green2@sth.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Mark Davies</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chris Blundell</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carolyn Chadwick</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Howard Davies</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal National Orthopaedic Hospital NHS Trust</name>
      <address>
        <city>Stanmore</city>
        <zip>HA7 4LP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deirdre Brooking</last_name>
      <phone>020 8385 3042</phone>
      <email>deirdre.brooking@rnoh.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Karen Alligan</last_name>
      <email>karen.alligan@rnoh.nhs.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Andrew J Goldberg, MBBS MD FRCS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nick Cullen</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dishan Singh</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wrightington Hospital</name>
      <address>
        <city>Wigan</city>
        <zip>WN6 9EP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Val Parkinson</last_name>
      <phone>01257 256354</phone>
      <email>valerie.a.parkinson@wwl.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Mike Karski</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Timothy Clough</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rob Smith</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>James Davenport</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.anklearthritis.co.uk</url>
    <description>TARVA website</description>
  </link>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 11, 2014</study_first_submitted>
  <study_first_submitted_qc>April 29, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 1, 2014</study_first_posted>
  <last_update_submitted>October 26, 2017</last_update_submitted>
  <last_update_submitted_qc>October 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ankle arthritis</keyword>
  <keyword>osteoarthritis</keyword>
  <keyword>total ankle replacement</keyword>
  <keyword>arthrodesis</keyword>
  <keyword>quality of life</keyword>
  <keyword>musculoskeletal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

